NO20012538L - Use of N-substituted azabicycloalkane derivatives for the treatment of central nervous system disorders - Google Patents

Use of N-substituted azabicycloalkane derivatives for the treatment of central nervous system disorders

Info

Publication number
NO20012538L
NO20012538L NO20012538A NO20012538A NO20012538L NO 20012538 L NO20012538 L NO 20012538L NO 20012538 A NO20012538 A NO 20012538A NO 20012538 A NO20012538 A NO 20012538A NO 20012538 L NO20012538 L NO 20012538L
Authority
NO
Norway
Prior art keywords
nervous system
central nervous
treatment
system disorders
substituted
Prior art date
Application number
NO20012538A
Other languages
Norwegian (no)
Other versions
NO20012538D0 (en
Inventor
Rainer Munschauer
Gerd Steiner
Gerhard Gross
Martin Traut
Liliane Unger
Hans-Juergen Teschendorf
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of NO20012538D0 publication Critical patent/NO20012538D0/en
Publication of NO20012538L publication Critical patent/NO20012538L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)

Abstract

Det er beskrevet anvendelse av N-substituerte 3-azabicykloalkanderivater med formel l hvori B, R1, R2 og n er som definert heri for kontrahering av avhengighetsforstyrrelser og andre forstyrrelser i sentralnervesystemet.The use of N-substituted 3-azabicycloalkane derivatives of formula I wherein B, R1, R2 and n are as defined herein for contracting addiction disorders and other disorders of the central nervous system is disclosed.

NO20012538A 1998-11-24 2001-05-23 Use of N-substituted azabicycloalkane derivatives for the treatment of central nervous system disorders NO20012538L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19854147A DE19854147A1 (en) 1998-11-24 1998-11-24 Control of cocaine addiction comprises administration of N-substituted azabicycloalkane derivative
PCT/EP1999/008734 WO2000030639A1 (en) 1998-11-24 1999-11-12 Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system

Publications (2)

Publication Number Publication Date
NO20012538D0 NO20012538D0 (en) 2001-05-23
NO20012538L true NO20012538L (en) 2001-07-04

Family

ID=7888824

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012538A NO20012538L (en) 1998-11-24 2001-05-23 Use of N-substituted azabicycloalkane derivatives for the treatment of central nervous system disorders

Country Status (21)

Country Link
EP (1) EP1133293A1 (en)
JP (1) JP2002530333A (en)
KR (1) KR20010080535A (en)
CN (1) CN1328455A (en)
AR (1) AR021502A1 (en)
AU (1) AU1775300A (en)
BG (1) BG105549A (en)
BR (1) BR9915589A (en)
CA (1) CA2352526A1 (en)
CZ (1) CZ20011796A3 (en)
DE (1) DE19854147A1 (en)
HK (1) HK1040933A1 (en)
HR (1) HRP20010472A2 (en)
HU (1) HUP0104416A3 (en)
IL (1) IL143181A0 (en)
NO (1) NO20012538L (en)
PL (1) PL348758A1 (en)
SK (1) SK7112001A3 (en)
TR (1) TR200101476T2 (en)
WO (1) WO2000030639A1 (en)
ZA (1) ZA200103976B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1836183A2 (en) 2004-12-13 2007-09-26 Galileo Pharmaceuticals, Inc. Spiro derivatives as lipoxygenase inhibitors
GB0812310D0 (en) 2008-07-03 2008-08-13 Syngenta Ltd Novel herbicides
WO2014111837A1 (en) * 2013-01-15 2014-07-24 Novartis Ag Use of alpha 7 nicotinic acetylcholine receptor agonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989004311A1 (en) * 1987-11-12 1989-05-18 American Home Products Corporation Polycyclicamines with psychotropic activity
DE4427648A1 (en) * 1994-08-04 1996-02-08 Basf Ag N-Stubstituted 3-azabicyclo [3,2,0,] heptane derivatives, their preparation and use
DE4341403A1 (en) * 1993-12-04 1995-06-08 Basf Ag N-substituted 3-azabicycloalkane derivatives, their preparation and use
DE4427647A1 (en) * 1994-08-04 1996-02-08 Basf Ag N-substituted azabicycloheptane derivatives, their preparation and use

Also Published As

Publication number Publication date
DE19854147A1 (en) 2000-05-25
BG105549A (en) 2001-12-29
HUP0104416A2 (en) 2002-04-29
PL348758A1 (en) 2002-06-03
HUP0104416A3 (en) 2002-11-28
EP1133293A1 (en) 2001-09-19
IL143181A0 (en) 2002-04-21
ZA200103976B (en) 2002-05-16
CN1328455A (en) 2001-12-26
HRP20010472A2 (en) 2003-04-30
AR021502A1 (en) 2002-07-24
SK7112001A3 (en) 2001-12-03
NO20012538D0 (en) 2001-05-23
HK1040933A1 (en) 2002-06-28
BR9915589A (en) 2001-08-07
CA2352526A1 (en) 2000-06-02
TR200101476T2 (en) 2001-10-22
WO2000030639A1 (en) 2000-06-02
AU1775300A (en) 2000-06-13
CZ20011796A3 (en) 2002-05-15
KR20010080535A (en) 2001-08-22
JP2002530333A (en) 2002-09-17

Similar Documents

Publication Publication Date Title
ATE264846T1 (en) SUBSTITUTED BENZIMIDAZOLE DERIVATIVES AND THEIR USE FOR TREATING RETROVIRAL INFECTIONS
SE9900100D0 (en) New compounds
DK0863875T3 (en) New 4- (oxyalkoxyphenyl) -3-oxy-piperines for the treatment of heart and kidney disorders
MXPA02006212A (en) Pyrrolidine derivatives as cyclic ampspecific phosphodiesterase inhibitors.
GEP20022676B (en) 4-Phenyl-Pyridine Derivatives, Method for Their Production and Their Use for Treatment of Disorders Caused by Antagonist of NK-1 Receptors
MXPA03012013A (en) Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives as medicaments for the treatment of pain.
DE69820632D1 (en) 2-PHENYL SUBSTITUTED 1- (N-PHENYLAMINOALKYL) PIPERAZINE DERIVATIVES
NO996108L (en) 9 oksinerytromycinderivater
NO986111D0 (en) Use of K-252A derivative for the treatment of peripheral and central nerve foci
NO990433L (en) New compounds and compositions for the treatment of diseases associated with tryptase activity
DK0765320T3 (en) Benzimidazolone derivatives with central dopaminergic activity
DK1578740T3 (en) 1,2,4-triaminobenzene derivatives suitable for the treatment of central nervous system disorders
ATE277072T1 (en) SAPOGENIN DERIVATIVES FOR THE TREATMENT OF COGNITIVE DISORDERS
DK0556332T3 (en) Substituted tetrahydropyridines and hydroxypiperidines as agents for the treatment of the central nervous system
NO20000957L (en) Branched alkoxy-substituted 2-aminopyridines as NOS inhibitors
CA2474510A1 (en) Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
FI970469A0 (en) Benzimidazole derivatives with dopaminergic activity
ES2191341T3 (en) DERIVATIVES OF 2-PHENOXIANILINE.
DK1000046T3 (en) Piperazine derivatives active on the lower urinary tract
NO20012538L (en) Use of N-substituted azabicycloalkane derivatives for the treatment of central nervous system disorders
NZ511997A (en) Isonipecotamides for the treatment of integrin-mediated disorders
AP2002002595A0 (en) Heterocyclic amide derivatives.
NO20010626L (en) N-substituted azabicycloheptane derivatives, their preparation and use
MY136138A (en) Hexacyclic compounds
ATE283269T1 (en) 5-(HETEROARYL)ALKYL)-3-OXO-PYRIDO(1,2-A)BENZIMIDAZOLE-4-CARBOXAMIDE (PBI) DERIVATIVES FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application